BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
82.00
+30.00 (57.69%)
Jul 4, 2025, 3:30 PM JST

TYO:4594 Revenue

In the fiscal year ending March 31, 2025, BrightPath Biotherapeutics had annual revenue of 1.13M JPY with 1,473.61% growth. BrightPath Biotherapeutics had revenue of 12.00M in the quarter ending December 31, 2018, a decrease of -81.25%.

Revenue
1.13M
Revenue Growth
-99.71%
P/S Ratio
4,153.17
Revenue / Employee
26.98K
Employees
42
Market Cap
4.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20251.13M1.06M1,473.61%
Mar 31, 202472.00K-353.93M-99.98%
Mar 31, 2018354.00M-175.00M-33.08%
Mar 31, 2017529.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition